Unlike standard GLP-1 compounds, Retatrutide activates three metabolic pathways instead of one, creating a broader physiological response
While the drug labels for many GLP-1 medications mentioned common side effects like nausea, vomiting, and diarrhea, it is alleged that they failed to adequately warn of the risk of developing severe, permanent conditions like gastroparesis
doi: 10.1210/clinem/dgaa863 190 LeeCJMaoHThieuVTLandLFThomasMK
To optimize outcomes, personalized treatment plans are key
International travel considerations If you are traveling abroad, check the destination countrys rules for importing prescription medications
Our retatrutide research peptide is produced with attention to purity, stability, and research-grade consistency